Dose-response effects of pegylated human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet production end function in nonhuman primates.

被引：0
|
作者：
Harker, LA
Hunt, P
Marzec, UM
Kelly, AB
Tomer, A
Hanson, SR
Stead, RB
机构：
[1] EMORY UNIV,SCH MED,ATLANTA,GA
[2] AMGEN INC,THOUSAND OAKS,CA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1012 / 1012
页数：1
相关论文
共 33 条
  • [21] Enhanced hematopoietic regeneration in primate model of myelosuppressive chemotherapy by pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in combination with granulocyte colony stimulating factor (G-CSF).
    Harker, LA
    Marzec, UM
    Kelly, AB
    Hanson, SR
    BLOOD, 1995, 86 (10) : 1976 - 1976
  • [22] Safety and biologic effect of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast canter patients following autologous peripheral blood progenitor cell transplantation (PBPC).
    Bolwell, B
    Vredenburgh, J
    Overmoyer, B
    Gilbert, C
    Chap, L
    Menchaca, D
    Scarlata, D
    Glaspy, J
    BLOOD, 1997, 90 (10) : 756 - 756
  • [23] Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation
    Bolwell, B
    Vredenburgh, J
    Overmoyer, B
    Gilbert, C
    Chap, L
    Menchaca, DM
    Cruickshank, S
    Glaspy, J
    BONE MARROW TRANSPLANTATION, 2000, 26 (02) : 141 - 145
  • [24] Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation
    B Bolwell
    J Vredenburgh
    B Overmoyer
    C Gilbert
    L Chap
    DM Menchaca
    S Cruickshank
    J Glaspy
    Bone Marrow Transplantation, 2000, 26 : 141 - 145
  • [25] A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia
    Archimbaud, E
    Ottmann, OG
    Yin, JAL
    Lechner, K
    Dombret, H
    Sanz, MA
    Heil, G
    Fenaux, P
    Brugger, W
    Barge, A
    O'Brien-Ewen, C
    Matcham, J
    Hoelzer, D
    BLOOD, 1999, 94 (11) : 3694 - 3701
  • [26] Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers
    Harker, LA
    Roskos, LK
    Marzec, NM
    Carter, RA
    Cherry, JK
    Sundell, B
    Cheung, EN
    Terry, D
    Sheridan, W
    BLOOD, 2000, 95 (08) : 2514 - 2522
  • [27] The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia
    Adams, JA
    Yin, JAL
    Brereton, ML
    Briggs, M
    Burgess, R
    Hyde, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (01) : 139 - 146
  • [28] Randomized, double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients (Pts) following autologous bone marrow transplantation (ABMT).
    Beveridge, R
    Schuster, M
    Waller, E
    Stuart, R
    Abboud, C
    Cruickshank, S
    Menchaca, D
    Macri, M
    Connaghan, DG
    BLOOD, 1997, 90 (10) : 2580 - 2580
  • [29] Effects of recombinant human megakaryocyte growth and development factor (rHuMGDF) on platelet aggregation and tyrosine phosphorylation of Jak2 and platelets.
    Nelson, A
    Varnum, B
    Toombs, C
    BLOOD, 1996, 88 (10) : 82 - 82
  • [30] Randomized, double-blind, placebo-controlled phase I trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) administered to patients with advanced cancer before and after chemotherapy - Early results.
    Basser, R
    Clarke, K
    Fox, R
    Green, M
    Cebon, J
    Marty, J
    Menchaca, D
    Tomita, D
    Begley, G
    BLOOD, 1995, 86 (10) : 1014 - 1014
1234